Halozyme Therapeutics, Inc. (HALO) Posts Q4 Loss of 4c/Share

February 25, 2013 4:08 PM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported Q4 EPS of ($0.04) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found